O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of O6-benzylguanine and carmustine in treating
children who have refractory CNS tumors. Drugs used in chemotherapy use different ways to
stop tumor cells from dividing so they stop growing or die. Combining more than one drug may
kill more tumor cells.